There is growing evidence that drugs of abuse alter processing of emotional information in ways that could be attractive to users. Our recent report that Δ9-tetrahydrocannabinol (THC) diminishes amygdalar activation in response to threat-related faces suggests that THC may modify evaluation of emotionally-salient, particularly negative or threatening, stimuli. In this study, we examined the effects of acute THC on evaluation of emotional images. Healthy volunteers received two doses of THC (7.5 and 15 mg; p.o.) and placebo across separate sessions before performing tasks assessing facial emotion recognition and emotional responses to pictures of emotional scenes. THC significantly impaired recognition of facial fear and anger, but it only marginally impaired recognition of sadness and happiness. The drug did not consistently affect ratings of emotional scenes. THC’s effects on emotional evaluation were not clearly related to its mood-altering effects. These results support our previous work, and show that THC reduces perception of facial threat. Nevertheless, THC does not appear to positively bias evaluation of emotional stimuli in general.
AdolphsRTranelDDamasioH. (1994) Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature372: 669–672.
2.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4 ed. Washington, DC: American Psychiatric Association.
3.
BambicoFRDurantiATontiniA. (2009) Endocannabinoids in the treatment of mood disorders: Evidence from animal models. Curr Pharm Des15: 1623–1646.
4.
BediGHymanDde WitH (2010) Is ecstasy an ‘Empathogen’? Effects of +/−3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry68: 1134–1140.
5.
BediGPhanKLAngstadtM. (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl)207: 73–83.
6.
BhattacharyyaSMorrisonPDFusar-PoliP. (2010) Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology35: 764–774.
7.
BlairRJCurranHV (1999) Selective impairment in the recognition of anger induced by diazepam. Psychopharmacology (Berl)147: 335–338.
8.
BorrillJARosenBKSummerfieldAB (1987) The influence of alcohol on judgement of facial expression of emotion. Br J Med Psychol60: 71–77.
9.
BrowningMReidCCowenPJ. (2007) A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol21: 684–690.
10.
ChaitLDFischmanMWSchusterCR (1985) ‘Hangover’ effects the morning after marijuana smoking. Drug Alcohol Depend15: 229–238.
11.
CinciripiniPMRobinsonJDCarterBL. (2006) The effects of smoking deprivation and nicotine administration on emotional reactivity. Nicotine Tob Res8: 379–392.
12.
CooperZDHaneyM (2009) Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence. Int Rev Psychiatry21: 104–112.
13.
CorneliusJRAizensteinHJHaririAR (2010) Amygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression. Addict Behav35: 644–646.
14.
CouplandNJSinghAJSustrikRA. (2003) Effects of diazepam on facial emotion recognition. J Psychiatry Neurosci28: 452–463.
15.
CraigLCAttwoodASBentonCP. (2009) Effects of acute alcohol consumption and alcohol expectancy on processing of perceptual cues of emotional expression. J Psychopharmacol23: 258–265.
16.
Del-BenCMFerreiraCASanchezTA. (2011) Effects of diazepam on BOLD activation during the processing of aversive faces. J Psychopharmacol26: 443–451.
17.
DonohueKFCurtinJJPatrickCJ. (2007) Intoxication level and emotional response. Emotion7: 103–112.
18.
DotyPde WitH (1995) Effect of setting on the reinforcing and subjective effects of ethanol in social drinkers. Psychopharmacology (Berl)118: 19–27.
19.
D’SouzaDCPerryEMacDougallL. (2004) The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology29: 1558–1572.
20.
D’SouzaDCRanganathanMBraleyG. (2008) Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology33: 2505–2516.
FischmanMWFoltinRW (1991) Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict86: 1563–1570.
23.
FolsteinMFLuriaR (1973) Reliability, validity, and clinical application of the visual analog mood scale. Psychol Med3: 8.
24.
Fusar-PoliPCrippaJABhattacharyyaS. (2009) Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry66: 95–105.
25.
Garcia-GutierrezMSManzanaresJ (2010) The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines. J Psychopharmacol24: 757–765.
26.
GilmanJMRamchandaniVADavisMB. (2008) Why we like to drink: A functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol. J Neurosci28: 4583–4591.
27.
GospicKGunnarssonTFranssonP. (2008) Emotional perception modulated by an opioid and a cholecystokinin agonist. Psychopharmacology (Berl)197: 295–307.
28.
GruberSARogowskaJYurgelun-ToddDA (2009) Altered affective response in marijuana smokers: An FMRI study. Drug Alcohol Depend105: 139–153.
29.
HarmerCJBhagwagarZPerrettDI. (2003) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology28: 148–152.
30.
HarmerCJHeinzenJO’SullivanUAyresRA. (2008) Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers. Psychopharmacology (Berl)199: 495–502.
31.
HarmerCJMackayCEReidCB. (2006) Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry59: 816–820.
32.
HarmerCJO’SullivanUFavaronE. (2009) Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry166: 1178–1184.
33.
HarmerCJShelleyNCCowenPJ. (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry161: 1256–1263.
34.
HorderJBrowningMDi SimplicioM. (2011) Effects of 7 days treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing. J Psychopharmacol26: 125–132.
35.
HorderJCowenPJDi SimplicioM. (2009) Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology (Berl)205: 85–91.
36.
HorderJHarmerCJCowenPJ. (2010) Reduced neural response to reward following 7 days treatment with the cannabinoid CB(1) antagonist rimonabant in healthy volunteers. Int J Neuropsychopharmacol13: 1103–1113.
37.
IlanABGevinsAColemanM. (2005) Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behav Pharmacol16: 487–496.
38.
KarschnerELDarwinWDMcMahonRP. (2011) Subjective and physiological effects after controlled Sativex and oral THC administration. Clin Pharmacol Ther89: 400–407.
39.
KatonaIRanczEAAcsadyL. (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of gabaergic transmission. J Neurosci21: 9506–9518.
40.
KirkJMDotyPde WitH (1998) Effects of expectancies on subjective responses to oral delta-9-tetrahydrocannabinol. Pharmacol Biochem Behav59: 287–293.
41.
KnowlesSKDukaT (2004) Does alcohol affect memory for emotional and non-emotional experiences in different ways?Behav Pharmacol15: 111–121.
42.
LangPJBradleyMMCuthbertBN (1999) International Affective Picture System (IAPS): Technical Manual and Affective Ratings. Gainesville, FL: NIMH Center for the Study of Emotion and Attention, University of Florida.
43.
LangPJGreenwaldMKBradleyMM. (1993) Looking at pictures: Affective, facial, visceral, and behavioral reactions. Psychophysiology30: 261–273.
44.
MackieK (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. In: PertweeRG (ed.) Cannabinoids. Handbook of Experimental Pharmacology, vol. 168. Heidelberg: Springer-Verlag.
45.
MartinWRSloanJWSapiraJD. (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther12: 245–258.
46.
MetrikJRohsenowDJMontiPM. (2009) Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol17: 217–225.
47.
MoreiraFAWotjakCT (2010) Cannabinoids and anxiety. Curr Top Behav Neurosci2: 429–450.
48.
OhmanA (2005) The role of the amygdala in human fear: Automatic detection of threat. Psychoneuroendocrinology30: 953–958.
PaulusMPFeinsteinJSCastilloG. (2005) Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. Arch Gen Psychiatry62: 282–288.
51.
PhanKLAngstadtMGoldenJ. (2008) Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci28: 2313–2319.
52.
PriceJLDrevetsWC (2010) Neurocircuitry of mood disorders. Neuropsychopharmacology35: 192–216.
53.
StrassmanRJQuallsCRUhlenhuthEH. (1994) Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry51: 98–108.
54.
StritzkeWGPatrickCJLangAR (1995) Alcohol and human emotion: A multidimensional analysis incorporating startle-probe methodology. J Abnorm Psychol104: 114–122.
TrevisaniDPJohnsonSLCarverCS (2008) Positive mood induction and facial affect recognition among students at risk for mania. Cognit Ther Res32: 639.
57.
VuilleumierPPourtoisG (2007) Distributed and interactive brain mechanisms during emotion face perception: Evidence from functional neuroimaging. Neuropsychologia45: 174–194.
58.
WachtelSRde WitH (2000) Naltrexone does not block the subjective effects of oral delta-9-tetrahydrocannabinol in humans. Drug Alcohol Depend59: 251–260.
59.
WachtelSRElsohlyMARossSA. (2002) Comparison of the subjective effects of delta-9-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl)161: 331–339.
60.
WardleMCde WitH (2012) Effects of amphetamine on reactivity to emotional stimuli. Psychopharmacology (Berl): 220: 143–153.
61.
WatsonDClarkLATellegenA (1988) Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol54: 1063–1070.
62.
YoungAWRowlandDCalderAJ. (1997) Facial expression megamix: Tests of dimensional and category accounts of emotion recognition. Cognition63: 271–313.
63.
ZanettiniCPanlilioLVAlickiM. (2011) Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci5: 57.
64.
ZangaraABlairRJCurranHV (2002) A comparison of the effects of a beta-adrenergic blocker and a benzodiazepine upon the recognition of human facial expressions. Psychopharmacology (Berl)163: 36–41.
65.
ZuardiAWShirakawaIFinkelfarbE. (1982) Action of cannabidiol on the anxiety and other effects produced by delta-9-thc in normal subjects. Psychopharmacology (Berl)76: 245–250.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
